Kristen Ambrose, SVP & Chief Accounting Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 357 shares at $483.36 ($173K) on 2026-02-26, disclosed to the SEC on 2026-03-02.
Scheduled sale ($173k) by SVP & Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VRTX | SELL | 2026-02-12 | $634K | — | Filing → |
| VRTX | SELL | 2025-02-26 | $850K | — | Filing → |
| VRTX | SELL | 2025-02-19 | $611K | — | Filing → |